The most important word in “liquid microneedling” might be the one the slogan leaves out: evidence. Sponge-spicule delivery systems have changed how selected molecules enter skin in laboratory and animal experiments. Those results do not automatically prove that a retail prickling serum improves wrinkles or matches an in-clinic procedure. (Zhang et al., 2019 — PMID: 30821312; Liang et al., 2020 — PMID: 32380414.)
This Science Journal investigation looks beyond the sensation to ask what was actually tested, in which model, and with which formulation.
L1 STRONG — Multiple RCTs or systematic reviews in humans
L2 MODERATE — Some clinical studies; limitations exist
L3 PRELIMINARY — Small studies or limited clinical evidence
L4 MECHANISTIC — Cellular, biochemical, or animal evidence only
L5 HYPOTHESIS — Interesting science; insufficient evidence
L4 describes the preclinical spicule-delivery evidence examined here. It is not a clinical endorsement of a retail product. L5 marks cosmetic conclusions not demonstrated by these studies.
In Plain English
Think of these studies as research into a delivery route, not a finished verdict on a beauty routine. Investigators combined sponge spicules with specially designed liposomes to move hyaluronic acid or small interfering RNA into skin. The complete delivery system matters, not just the presence of something called a spicule. (Zhang et al., 2019 — PMID: 30821312; Liang et al., 2020 — PMID: 32380414.)
Who This Is For
Readers considering a spicule serum, wondering what “liquid microneedling” actually means, or deciding whether a prickling product deserves a place beside their existing actives. This is not a DIY delivery protocol or instructions for making skincare penetrate more deeply.
1. A Microchannel Is a Mechanism, Not a Beauty Outcome L4 MECHANISTIC
A 2019 study investigated sponge Haliclona sp. spicules combined with flexible liposomes carrying hyaluronic acid. The researchers described microchannels in skin and enhanced delivery in porcine skin experiments, with additional work in BALB/c mice. That is a specific preclinical formulation and testing program, not a consumer trial of every product carrying a “reedle” or “micro-shot” label. (Zhang et al., 2019 — PMID: 30821312.)
The useful scientific question is not simply whether spicules can affect delivery. It is whether a particular finished product produces a meaningful benefit, at its intended dose and frequency, in the people expected to use it. The cited study cannot answer that for an untested retail formula.
2. The Liposome Is Not a Footnote L4 MECHANISTIC
In the hyaluronic-acid study, the combined system performed differently from its individual components. The experimental comparisons included spicules alone and a dermaroller combined with flexible liposomes. These comparisons concern delivery under the study conditions; they do not establish that a cosmetic spicule serum outperforms professional microneedling for scars, texture, or wrinkles. (Zhang et al., 2019 — PMID: 30821312.)
This is why ingredient-name shopping has limits. A delivery result belongs to the tested system and its methods. Swapping the carrier, ingredient, application technique, or concentration creates a different question.
3. Gene Silencing Is Not a Glow Score L4 MECHANISTIC
A 2020 study combined sponge spicules with cationic flexible liposomes to deliver small interfering RNA. It examined skin penetration in vitro and reduction of a target protein, GAPDH, in mice. This is a drug-delivery research endpoint, not evidence that users of a cosmetic serum will develop firmer skin or fewer wrinkles. (Liang et al., 2020 — PMID: 32380414.)
The study is interesting precisely because it is specific. Turning it into “spicules make everything work better” strips away the formulation, the cargo, the model, and the measured outcome.
4. Prickling Does Not Validate the Promise L5 · COSMETIC INFERENCE NOT ESTABLISHED HERE
Neither of these studies establishes a relationship between how much a consumer feels a product and how much their wrinkles improve. Neither provides a universal retail schedule or proof of equivalence to clinical microneedling. A sensation cannot substitute for the missing outcome data. (Zhang et al., 2019 — PMID: 30821312; Liang et al., 2020 — PMID: 32380414.)
“A clever way through the barrier is not the same as a proven reason to cross it.”
— The SS Perspective, editorial takeaway, not a quotation from a researcher.
⚠️ Honest Limitations
This article examines two preclinical delivery studies, not an exhaustive review of every spicule formulation. Laboratory skin and mouse findings cannot establish long-term human effectiveness, safety across skin tones, pregnancy suitability, or compatibility with prescription skincare. This does not mean no human research exists; it means these particular papers cannot carry those claims.
The 2019 paper reported minimal redness in its own irritation work. That is not a guarantee that every commercial formulation is gentle or appropriate for reactive skin. Its experimental observations about microchannel closure must not be turned into a universal consumer recovery timetable. (Zhang et al., 2019 — PMID: 30821312.)
For broken skin, an active rash, significant sensitivity, or uncertainty about combining a product with treatment, ask a qualified clinician first. Stop use and seek advice for persistent or worsening symptoms. Never use cosmetic spicules to try to deliver medicines through skin.
The SS Protocol L2 · INDIRECT BASIC-CARE RATIONALE
Our recommendation is a foundation-first routine, not a spicule treatment schedule. General support comes from moisturizer literature and sunscreen research, neither of which tested the products below after spicule use. (Purnamawati et al., 2017 — PMID: 29229630; Hughes et al., 2013 — PMID: 23732711.)
AM: Keep the Baseline Consistent
Use familiar, comfortable skincare and label-directed sun protection. ILLIYOON Ceramide Ato Concentrate Cream is a moisturizer option; Beauty of Joseon Relief Sun SPF50+ PA++++ is a sunscreen option. Neither is presented as a spicule equivalent or a treatment for adverse reactions.
PM: Do Not Build a Penetration Stack
Our conservative recommendation is not to add a spicule product alongside several unfamiliar actives or use it to intensify prescription treatments. If considering a finished product, review its own directions and contraindications and obtain individualized advice when needed. Do not exceed directions because a stronger sensation seems more convincing.
Weekly: Review Before Repeating
There is no evidence-derived universal weekly schedule in the cited studies for retail spicule skincare. Keep a record of what you use and how your skin feels. No optional cosmetic step is worth pushing through persistent discomfort.
🛒 Shop This Protocol
ILLIYOON Ceramide Ato Concentrate Cream →
A moisturizer option for your basic routine.
Beauty of Joseon Relief Sun SPF50+ PA++++ →
A sunscreen option to use according to its label.
These supportive shopping suggestions were not tested in the spicule studies and are not a substitute for clinical advice.
Stack It With / Don't Stack It With
Stack it with: realistic expectations, a stable baseline routine, and careful attention to the finished product’s directions.
Don't stack it with: DIY drug delivery, another skin-disrupting procedure, or a “more sting means more results” rule. These are conservative editorial recommendations, not clinically tested combinations.
Skin Type Customization
Dry or reactive: prioritize comfort and consider skipping an optional experimental step. A clinician can help assess persistent irritation.
Acne-prone: do not substitute a delivery mechanism for a diagnosed acne treatment plan.
Prone to lingering marks: ask about suitability before trying a new skin-disrupting approach; these papers do not establish outcomes for your skin tone or history.
Already using prescription skincare: ask the prescriber before introducing a product marketed to alter penetration. Do not infer compatibility from a social-media routine.
📅 Results Timeline
No human wrinkle, scar, or glow timeline can be derived from these two delivery studies. An experimental microchannel observation is not a promise about when your skin will recover or when you should reapply a retail serum. Require human outcome data for the exact finished formula before accepting a precise results claim. (Zhang et al., 2019 — PMID: 30821312; Liang et al., 2020 — PMID: 32380414.)
The SS Perspective
Spicule research deserves curiosity, not a free pass from evidence standards. The strongest question is not “Can I feel it working?” but “What was measured in people using this exact formula?” Until that answer is convincing, a simpler routine is not falling behind. It is keeping the burden of proof where it belongs: on the product making the promise.
Build the Foundation First
Start with a barrier-care framework and consistent sun protection, not a race to increase penetration.
Robert Lee
The Serum Scientist — Founder, SerumScientist.com
📖 References
Zhang C, Zhang K, Zhang J, Ou H, Duan J, Zhang S, Wang D, Mitragotri S, Chen M. Skin delivery of hyaluronic acid by the combined use of sponge spicules and flexible liposomes. Biomaterials Science. 2019;7(4). PMID: 30821312.
Liang X, Zhang J, Ou H, Chen J, Mitragotri S, Chen M. Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes. Molecular Therapy Nucleic Acids. 2020;20. PMID: 32380414.
Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The Role of Moisturizers in Addressing Various Kinds of Dermatitis: A Review. Clinical Medicine & Research. 2017;15(3–4):75–87. PMID: 29229630.
Hughes MC, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine. 2013;158(11):781–790. PMID: 23732711.
📚 Further Reading
Skin Barrier Repair Protocol
Dermaplaning: Smooth Skin Is Not a Barrier Reset
The Skin Barrier Decoded
© 2026 SerumScientist.com. All rights reserved. This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any new skincare regimen.
0 comments